PDF(903 KB)
Treatment of congenital hyperinsulinism with octreotide: a case report
HU Shu-Wen, LIU Min, SANG Yan-Mei
Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (5) : 392-393.
PDF(903 KB)
PDF(903 KB)
Treatment of congenital hyperinsulinism with octreotide: a case report
［1］Flanagan SE, Kapoor RR, Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia［J］. Semin Pediatr Surg, 2011, 20(1): 13-17.
［2］Bruining GJ. Recent advances in hyperinsulinism and pathogenesis of diabetes mellitus［J］. Curr Opin Pediatr, 1990, 2: 758-765.
［3］桑艳梅，苞山.先天性高胰岛素血症的遗传发病机制及诊疗进展［J］.中国糖尿病杂志， 2009， 17（9）：713-715.
［4］Glaser B, Blech I, Krakinovsky Y, Ekstein J, Gillis D, Mazor-Aronovitch K, et al. ABCC8 mutation allele frequency in the Ashkenazi Jewish population and risk of focal hyperinsulinemic hypoglycemia［J］. Genet Med, 2011, 13(10): 891-894.
［5］De León DD, Stanley CA. Mechanism of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates［J］. Nat Clin Pract Endocrinol Metab, 2007, 3(1): 57-68.
［6］Modan-Moses D, Koren I, Mazor-Aronovitch K, Pinhas-Hamiel O, Landau H. Treatment of congenital hyperinsulinism with lanreotide acetate (somatuline autogel)［J］. Clin Endocrinol Metab, 2011, 96(8): 2312-2317.
［7］Laje P, Halaby L, Adzick NS, Stanley CA. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism［J］. Pediatr Diabetes, 2010,11(2): 142-147.
